Mol. Cell. Biol. doi:10.1128/MCB.02152-06
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
Glucocorticoid and Growth Factor Synergism Requirement for Notch4 Chromatin Domain Activation
Jing Wu
and
Emery H. Bresnick*
University of Wisconsin School of Medicine, Department of Pharmacology, 1300 University Avenue, Madison, WI 53706
* To whom correspondence should be addressed. Email:
ehbresni{at}wisc.edu.
 |
Abstract |
|---|
The Notch signaling pathway modulates cell fate in diverse contexts, including vascular development. Notch4 is selectively expressed in vascular endothelium and regulates vascular remodeling. The signal-dependent transcription factor Activator Protein 1 (AP-1) activates Notch4 transcription in endothelial cells, but other factors/signals that regulate Notch4 are largely unknown. We demonstrate that, unlike the established transrepression mechanism in which the glucocorticoid receptor (GR) antagonizes AP-1, AP-1 and GR synergistically activated Notch4 transcription in endothelial cells. Fibroblast Growth Factor-2 (FGF-2) and cortisol induced AP-1 and GR occupancy, respectively, at a Notch4 promoter composite response element, consisting of an imperfect half GRE and an AP-1 motif, which mediated signal-dependent activation. Analysis of Notch4 promoter complex assembly provided evidence that GR and AP-1 independently occupy the composite response element, but AP-1 stabilizes GR occupancy. In multipotent 10T1/2 cells, FGF-2 and cortisol induced a histone modification pattern at the Notch4 locus mimicking that present in endothelial cells and reprogrammed Notch4 from a repressed to an active state. These results establish the molecular basis for a novel AP-1/GR - Notch4 axis in vascular endothelium.